Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clyde W Yancy

Showing results (91-100 of 647) with videos related to

Pageof 65
Sort By:
JAMA Cardiology|April 16, 2020
Anticipating a New Era in Heart TransplantationClyde W Yancy, Gregg C Fonarow
Current Treatment Options in Cardiovascular Medicine|July 12, 2005
Treatment of the African-American patient with congestive heart failureSandeep A Kamath, Clyde W Yancy
JAMA Cardiology|May 26, 2018
The New Hypertension Guidelines: Compelling Population Benefit, Manageable Risk, and Time to ImplementClyde W Yancy, Gregg C Fonarow
JAMA Cardiology|November 10, 2016
High-Intensity Statins for Secondary PreventionRobert O Bonow, Clyde W Yancy
Journal of the American College of Cardiology|June 22, 2019
Heart Failure Management Under PressureAdam D DeVore, Clyde W Yancy
American Journal of Preventive Cardiology|September 29, 2025
Health disparities; is there progress?Clyde W Yancy, Heather M Johnson
JAMA Cardiology|June 1, 2017
New Blood Pressure-Lowering Targets-Finding ClarityClyde W Yancy, Robert O Bonow
JAMA Cardiology|March 17, 2021
Is the Left Ventricular Ejection Fraction Measurement Still Preeminent?-New Measures to Quantify Subclinical Systolic DysfunctionClyde W Yancy, Gregg C Fonarow
JAMA Cardiology|February 17, 2021
Expediting the Benefits of Sodium-Glucose Cotransporter-2 Inhibitors for Heart Failure-There Is No Time for DelayGregg C Fonarow, Clyde W Yancy
JAMA Cardiology|July 20, 2016
Heart Failure-A New Phenotype EmergesJane E Wilcox, Clyde W Yancy
Pageof 65

Showing results (91-100 of 647) with videos related to

Sort By:
Pageof 65
JAMA Cardiology|April 16, 2020
Anticipating a New Era in Heart TransplantationClyde W Yancy, Gregg C Fonarow
Current Treatment Options in Cardiovascular Medicine|July 12, 2005
Treatment of the African-American patient with congestive heart failureSandeep A Kamath, Clyde W Yancy
JAMA Cardiology|May 26, 2018
The New Hypertension Guidelines: Compelling Population Benefit, Manageable Risk, and Time to ImplementClyde W Yancy, Gregg C Fonarow
JAMA Cardiology|November 10, 2016
High-Intensity Statins for Secondary PreventionRobert O Bonow, Clyde W Yancy
Journal of the American College of Cardiology|June 22, 2019
Heart Failure Management Under PressureAdam D DeVore, Clyde W Yancy
American Journal of Preventive Cardiology|September 29, 2025
Health disparities; is there progress?Clyde W Yancy, Heather M Johnson
JAMA Cardiology|June 1, 2017
New Blood Pressure-Lowering Targets-Finding ClarityClyde W Yancy, Robert O Bonow
JAMA Cardiology|March 17, 2021
Is the Left Ventricular Ejection Fraction Measurement Still Preeminent?-New Measures to Quantify Subclinical Systolic DysfunctionClyde W Yancy, Gregg C Fonarow
JAMA Cardiology|February 17, 2021
Expediting the Benefits of Sodium-Glucose Cotransporter-2 Inhibitors for Heart Failure-There Is No Time for DelayGregg C Fonarow, Clyde W Yancy
JAMA Cardiology|July 20, 2016
Heart Failure-A New Phenotype EmergesJane E Wilcox, Clyde W Yancy
Pageof 65